Log In
Print
BCIQ
Print
Print this Print this
 

daclatasvir (BMS-790052)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionSelective HCV NS5A protein inhibitor
Molecular Target HCV NS5A protein
Mechanism of ActionHCV non-structural protein 5A inhibitor
Latest Stage of DevelopmentPhase III
IndicationHepatitis C virus (HCV)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today